BOSTON SCIENTIFIC CORP — Director's Dealing 2024

Feb 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2024-02-06

Reporting Person: Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-06	Common Stock	A	22666.0000	$0.0000	Acquired	37733.0000	Direct
2024-02-06	Common Stock	F	9722.0000	$0.0000	Disposed	28011.0000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2542.0000	Indirect

Footnotes

F1: On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Total Shareholder Return Performance Share Program, with the actual number to be earned by the reporting person to be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Health Care Index over the three-year performance cycle comprising the three-year period ended December 31, 2023 and subject to the completion of the concurrent three-year individual service period. On February 6, 2024, the number of performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied.

F2: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.